Subscribe to RSS Feed
Medicines-Diabetes Treatment-Veropharm-Pharmasoft-Serono-NovoNordisk-Teva-GSK-Glenmark-Shering-Plau-Chiesi-OrionPharma-Madaus-ALKALOID-Torrent-ICN-Bristol-Myers Squibb-SUNpharma-Vetprom-Dompe-Farmak-Zambon-Dolorgiet-Pliva-Hexal-НПЦРИЗ-Canada Peptides-Фармстандарт-Лексредства ОАО
Ozempic® (Semavik) 0,25/0,5/1 mg/dose solution for subcutaneous administration 3 ml syringe pen 1 pc.
Ozempic is a self-injectable medication that contains the active ingredient, semaglutide. Previously, it has been prescribed ‘off label’ for weight loss, but it is licensed in the UK for treating type 2 diabetes. Semaglutide is available as a weight loss injection under the brand name Semavik.
Medicines-Diabetes Treatment-Veropharm-Pharmasoft-Serono-NovoNordisk-Teva-GSK-Glenmark-Shering-Plau-Chiesi-OrionPharma-Madaus-ALKALOID-Torrent-ICN-Bristol-Myers Squibb-SUNpharma-Vetprom-Dompe-Farmak-Zambon-Dolorgiet-Pliva-Hexal-НПЦРИЗ-Canada Peptides-Фармстандарт-Лексредства ОАО
Currently Shopping by
- The purpose of the medication: Remove This Item Diabetes Treatment
-
Manufacturer:
Veropharm
Pharmasoft
Serono
NovoNordisk
Teva
GSK
Glenmark
Shering-Plau
Chiesi
OrionPharma
Madaus
ALKALOID
Torrent
ICN
Bristol-Myers Squibb
SUNpharma
Vetprom
Dompe
Farmak
Zambon
Dolorgiet
Pliva
Hexal
НПЦРИЗ
Canada Peptides
OTCPharm JSC
- The purpose of the medication
- Manufacturer
